Category Archives: Vaping

Vaping specialist's sports nutrition and wellness revenue almost tripled during the first half of its financial year, according to new figures.

Supreme plc has confirmed the division's revenue jumped by 192% during the six months to the end of September 2021.

The Manchester-based vaping, lighting and batteries group also reported an overall revenue of 61m, up from the 56.3m it achieved during the same period in 2020.

READ MORE: Sizable Boohoo stake snapped up by Norway's central bank

The company's pre-tax profits also rose from 6.7m to 8.4m, according to figures filed with the London Stock Exchange.

The AIM-listed group added that its vaping revenue grew by 13%.

Chief executive Sandy Chadha said: "The combination of Supreme's extensive retail relationships combined with our high volume, great value product proposition continued to underpin our strong profit performance in the first six months of trading in the current financial year.

BusinessLive is your home for business news from around the North West- and you can stay in touch with all the latest news from Greater Manchester, Liverpool City Region, Cheshire, Lancashire and Cumbria through our email alerts.

You can sign up to receive daily morning news bulletins from every region we cover and to weekly email bulletins covering key economic sectors from manufacturing to technology and enterprise. And we'll send out breaking news alerts for any stories we think you can't miss.

Visit our email preference centre to sign up to all the latest news from BusinessLive.

For all the latest stories, views, polls and more - and the news as it breaks - follow our BusinessLive North West LinkedIn page here.

"Our market-leading Vaping category, alongside our high growth Sports Nutrition & Wellness division, continue to outperform their respective markets - further demonstrating our ability to attract and maintain consumer demand.

"When combined with the operational developments we have implemented, including the acquisitions of Vendek and Sci-MX alongside the launches of Millions & Millions and Sealions, this has been an important period for our business, as we continue to leverage our unique capabilities and integrated approach to accelerate performance.

"The second half of the current financial year has started well and our established business model, alongside our diverse product portfolio, provides the board with confidence in the group delivering a good performance in the second half and beyond."

Visit link:

Sports nutrition and wellness sales almost triple for vaping specialist Supreme - Business Live

New Zealands first medicinal cannabis conference was held in November 2020 and less than a year later, registrations were open for MedCan 2021. Academics, researchers, government officials, doctors, business people, investors, entrepreneurs and innovators, growers, and patients cannot afford to miss Octobers MedCan Summit 2021. It marks the sunrise industrys true starting line, as local producers are taking positive steps towards being in market, read a release announcing the 2021 Summit, earlier this year.

Executive Director of BioTechNZ and MedCan Summit 2021 organiser, Dr Zahra Champion, had explained that with over $100 million invested in the local medicinal cannabis industry 2021 is our year to shine. MedCan 2021 will help local companies accelerate their path to market through valuable insights to exporting, innovation and education. Well present the latest medical and scientific findings and breakthrough technologies, and well explore the current challenges and opportunities around the likes of investment, agritech, pharma manufacturing, and clinical trials, she said.

Unfortunately, due to the ongoing Covid-19-related restrictions, the event has had to be postponed, and has now been set for the 10th and 11th of February next year at Aucklands Cordis hotel.

The event aims to connect medicine, industry, science and technology, and will feature leading international and national thought leaders. The areas covered in the discussions will include seed to sale, clinical trials, prescribing, patient case studies, as well as the social, cultural and economic benefits of the products to New Zealand.

This has been a long journey. Its nearly three years since the enabling legislation was passed in Parliament and over 18 months since New Zealands Medicinal Cannabis Scheme took effect. The local industry is starting to roll-out high quality and affordable products for Kiwi patients, but theres still so much more to come, said Champion.

She highlighted that despite being moved, the summit has still gathered momentum with additional sponsors, exhibitors and speakers joining, and an updated two-day programme is now available on MedCans website http://www.medcansummit.co.nz. The program outlines details pertaining to Industry and Science streams, as well as the Healthcare Professionals Forum.

The Cannabis Law Reforms Taking Place in Europe

Go here to read the rest:

New Zealand's Medicinal Cannabis Summit Moved to February 2022 New Zealand's Medicinal Cannabis Summit Moved to February 2022 - Vaping Post

LONDON--(BUSINESS WIRE)--Innokin presents its "Why Smoke?" campaign in London, featuring branded buses, vans, and projection displays on buildings throughout the city.

Innokin is proud to create a vaping awareness campaign in the UK for the first time in two years. The "Why Smoke?" campaign is meant to make us think about our habits, even just for a moment. The campaign aims to inform smokers that there is an accessible, less harmful option to traditional cigarettes.

Advertising vaping products is a challenging task. There are many regulatory considerations, and this can make it very difficult to deliver a compelling message. Innokin is investing in vaping advocacy through a combination of traditional and innovation-led channels, intending to start an honest conversation about tobacco harm reduction.

Innokins "Why Smoke?" campaign began November 26th. Mobile billboards traveled throughout north and central London for four days, stopping in prominent areas to reach thousands of people each day. The mobile billboards introduce Innokins message to people all over the city.

On November 28th, large mobile projections displayed impactful messages on iconic London buildings over two days. The projection locations were selected based on high foot traffic in densely populated areas. The projections are a mix of vaping awareness messages and promotional displays for the MVP Pod, Innokins newest vaping device.

On November 29th, Innokins traditional media campaign began. The "Why Smoke?" message, along with promotional displays for the brand new MVP Pod, appear on five-hundred buses throughout the British capital for two weeks. Garnering the general public's attention is crucial to helping smokers transition to vaping.

Innokin has run promotional campaigns in the UK before. Previously, the vaping giant has partnered with the EFL to promote displays in football stadiums throughout the country and created two successful bus campaigns. Innokin is determined to help millions of smokers, not just in the UK but worldwide. Making cigarettes a thing of the past continues to be the firms priority. "Why Smoke?" is just the beginning of Innokins mission to create a smoke-free future.

For more information about this campaign, please visit Innokin Official Website for the details.

View post:

Innokin's Why Smoke? Vaping Campaign Hits the Streets of London - Business Wire

Earlier this year, a public consultation about the proposal to ban flavours was meant to close on the 19th of January, but had been extended to the 2nd of February. A statement published on the Netherlands Government website, had revealed that the consultation was extended due to popular demand.

An overwhelming majority of the responses, 98.54%, opposed the ban.

The WVA had already organized two light installations to protest the ban. The Covid-friendly light shows were projected onto landmark buildings in the Hague, starting at 18.00 and ending before curfew.

Subsequently, on the morning that members of the Health Committee met to discuss the ban last Summer, the WVA held another protest outside the House of Representatives. Vapers and vape shop owners handed out samples of disgusting tasting ice creams, in a bid to remind MPs and the public the importance of flavours and how they are vital in encouraging smokers to switch.

When this proposal was put to public consultation it received one of the biggest ever responses, with 98% of respondents opposing the ban. The message to the State Secretary was clear vaping flavours help smokers quit, and there is huge opposition to his ridiculous plan. Vapers are outraged that a caretaker Government would continue pushing for this proposed ban after such a loud and clear message, said Director of the World Vapers Alliance, Michael Landl.

A flavour ban for vaping would be a public health disaster for the Netherlands. It is incredible that a caretaker government would try to introduce such deeply controversial legislation, that would have such negative consequences for so many, before a new Government is formed, WVA Director Michael Landl concluded.

Reflecting Landls comments, a recent study looking into the flavour ban set in the US city of San Francisco, reported alarming findings. Titled, The Impact of a Comprehensive Tobacco Flavour Ban in San Francisco Among Young Adults, the current study was conducted with the aim of determining the impact of the ban on tobacco use behavior. A sample of 247 San Francisco residents were surveyed about their e-cigarette and tobacco use, before and after the flavour ban.

The study found that while the ban did lead to a decline in e-cigarettes and cigars sales, it sadly also caused a spike in smoking rates. Additionally, the researchers found that the measure was not enforced properly and 65% of participants reported being able to obtain flavoured products in multiple ways.

These findings suggest that comprehensive local flavor bans, by themselves, cannot sharply reduce the availability or use of flavored tobacco products among residents. Nevertheless, local bans can still significantly reduce overall e-cigarette use and cigar smoking but may increase cigarette smoking, concluded the study.

FDA Revokes Marketing Denial Orders for Humbles Flavoured E-liquids

View original post here:

Netherlands' Protests Highlighting The Importance of Vape Flavours - Vaping Post

While the Climate-related COP26 allowed the attendance of 2,360 NGOs, the FCTC COP9 just allowed 21 handpicked NGOs.

The COP9 virtual conference was (as in previous years) closed off to the public and only accessible to a handful of selected media representatives. While the Climate-related COP26 allowed the attendance of 2,360 NGOs, the FCTC COP9 just allowed 21 handpicked NGOs. Sadly, none of these represented populations who will be affected by the decisions taken at the conference.

The WHO organizes the conference, and is renowned for remaining staunchly opposed to the use of safer nicotine products, despite the significant independent and international scientific evidence indicating their efficacy for smoking cessation. In its most recent report, Fighting The Last War: The WHO and International Tobacco Control, the Global State of Tobacco Harm Reduction argues that tragically, the WHOs tobacco control policy is frozen in time, costing millions their lives.

As the WHO publishes its latest Global tobacco trends report, it trumpets falling tobacco use. But the global health institution is celebrating failure. To see numbers reduce from 1.32 billion to 1.30 billion tobacco users over five years cannot be argued as evidence of a successful strategy. Eight million lives are lost every year due to smoking-related disease. What we are seeing is evidence of a dereliction of public health duty, says the report.

With modern safer nicotine products, these technological disruptors such as vaping devices, nicotine pouches, heated tobacco products, we have the means at our disposal to end smoking and to end it soon. Global State of Tobacco Harm Reduction estimates put the number of users of harm reduction products at 100 million worldwide. Many smokers are put off from switching though, as a direct consequence of the distortion of public health messaging from the WHO and other tobacco control organisations funded by US philanthropic interests that seem to care little for the health of current smokers.

Harm reduction is the third pillar of the tobacco control strategy named in the FCTC (1), along with supply and demand reduction. We urge the WHO to integrate harm reduction into its approach to tobacco control, as it already does for drug use and HIV/AIDS prevention, and to address current deficits in the WHOs MPOWER strategy by enabling it to become EMPOWERED adding Engage with affected communities, Encourage smokers to switch to safer nicotine products and Deliver accurate information about safer alternatives.'(2)

New GSTHR Report: Fighting The Last War: The WHO and International Tobacco Control

Continue reading here:

FCTC COP9: WHO Reported Dropping Tobacco Use But Data Show Otherwise FCTC COP9: WHO Reported Dropping Tobacco Use But Data Show Otherwise - Vaping...

OLDHAM is hosting a vaping world cup in a bid to tackle misconceptions around e-cigarettes.

Run on a similar structure to the FIFA World Cup, the competition will see representatives from five vape brands, from countries including China and Malaysia, descend upon Oldhams Kick Sonic arena in a battle to become the top 5-a-side team.

Todays football competition is the brainchild of Oldham based iBreathe, one of the globes first manufacturers of e-cigarettes.

Billy Rahman, the chief executive of iBreathe, said: We want this World Cup to act as an awareness-raiser and convince people that the real evidence says vaping reduces smoking, illness, deaths and expensive emergency hospital care.

Vaping is now the NHSs preferred method of weaning people off cigarettes, but we are being hampered by spurious so-called scientific research and the kind of prejudice that could see all those positives go up in smoke.

E-cigarette allow users to inhale nicotine in a vapour rather than smoke and do not burn tobacco or produce tar or carbon monoxide, two of the most damaging elements in tobacco smoke.

A major UK clinical trial published in 2019 found that, when combined with face-to-face support, people who used e-cigarettes to quit smoking were twice as likely to succeed compared to those who used other nicotine replacement products, such as patches or gum.

iBreathe is hoping to raise money for local health charities through the event, including Oldham GP Dr Anita Sharmas charity Endometriosis Awareness North and the Greater Manchester charity Lagans Foundation which provides carers for children with heart defects.

Dr Sharma is set to speak to the teams plus other health chiefs at a ceremony immediately after the Vaping World Cup.

She said: There are a number of alternatives available to smokers to reduce the amount of toxins they put into their bodies and avoid conditions such as COPD, lung, and tongue cancer. But present evidence suggests vaping may be the most effective method.

You would never persuade someone with obesity to get healthier by telling them not to eat, you would offer them an incentive and alternative. I feel the same about e-cigarettes, and since they seem to work for most smokers, more power to them.

See more here:

Vaping World Cup to be held in Oldham - theoldhamtimes.co.uk

The latest vaping study from Keck School of Medicine of USC shows that, like smoking, use of e-cigarettes is linked to dysregulation of mitochondrial genes and immune response genes.

Since they hit the market, e-cigarettes have been touted as a safe alternative to tobacco cigarettes for adult smokers. When research began to suggest otherwise, many questioned whether smoking was still to blame for adverse effects, since most vapers are either dual users who also smoke cigarettes or have a prior history of smoking.

Now, a team of researchers at the Keck School of Medicine of USC has demonstrated that independent of the effects of prior smoking using e-cigarettes is linked to adverse biological changes that can cause disease. The study, published in Scientific Reports, revealed that vapers experience a similar pattern of changes to gene regulation as smokers do, although the changes are more extensive in people who smoke.

Our study, for the first time, investigates the biological effects of vaping in adult e-cigarette users, while simultaneously accounting for their past smoking exposure, said Ahmad Besaratinia, PhD, corresponding author and professor of research population and public health sciences at the Keck School of Medicine. Our data indicate that vaping, much like smoking, is associated with dysregulation of mitochondrial genes and disruption of molecular pathways involved in immunity and the inflammatory response, which govern health versus disease state.

The researchers recruited a diverse group of 82 healthy adults and separated them into three categories: current vapers, with and without a prior history of smoking; people who exclusively smoke cigarettes; and a control group of never-smokers and never-vapers. They conducted comprehensive in-person interviews to get a detailed vaping and smoking history from each participant. The team verified the histories by performing biochemical analyses on the participants blood to measure the concentration of cotinine, a breakdown product of nicotine.

Using next generation sequencing and bioinformatic data analysis, researchers then conducted a genome-wide search for changes in gene regulation in the blood cells of each of the participants. When the normal regulation of genes is disrupted and genes become dysregulated, that dysregulation can interfere with gene function, leading to disease.

For current vapers, they further performed computational modeling to determine whether the detected gene dysregulation was associated with the intensity and duration of their current vaping or the intensity and duration of their past smoking.

We found that more than 80% of gene dysregulation in vapers correlated with the intensity and duration of current vaping, said Besaratinia. Whereas none of the detected gene dysregulation in vapers correlated to their prior smoking intensity or duration.

In previous research, Besaratinia and his team have shown that e-cigarette users develop some of the same cancer-related molecular changes in oral tissue as cigarette smokers. They also discovered vapers had the same kind of cancer-linked chemical changes to their genome as smokers.

In this study, they found that, in both vapers and smokers, mitochondrial genes are preferential targets of gene dysregulation. They also found that vapers and smokers had significant dysregulation of immune response genes.

Besaratinia says the findings are not only novel and significant, but they are also interrelated, since growing evidence shows that mitochondria play a critical role in immunity and inflammation.

When mitochondria become dysfunctional, they release key molecules, said Besaratinia. The released molecules can function as signals for the immune system, triggering an immune response that leads to inflammation, which is not only important for maintaining health but also plays a critical role in the development of various diseases, such as cardiovascular and respiratory diseases, metabolic diseases, and cancer.

Adults arent the only ones vaping. The Centers for Disease Control estimates that more than 2 million middle and high school students in the U.S. report using e-cigarettes. Besaratinia says that this is one of the main reasons why the teams research is so critical to informing policy around vaping.

Given the popularity of e-cigarettes among young never-smokers, our findings will be of importance to the regulatory agencies, said Besaratinia. To protect public health, these agencies are in urgent need of scientific evidence to inform the regulation of the manufacture, distribution, and marketing of e-cigarettes.

Next, the team plans to identify and investigate chemicals common to both e-cigarette vapor and cigarette smoke to find out which ones might be causing similar adverse effects in vapers and smokers.

About this study

In addition to Besaratinia, the studys other authors are Stella Tommasi, Niccolo Pabustan and Kimberly D. Siegmund, of the Keck School of Medicine of USC and Meng Li and Yibu Chen of USC Libraries Bioinformatics Service.

This work was supported by grants from the National Cancer Institute of the National Institutes of Health (1R21CA268197) and the University of California Tobacco-Related Disease Research Program (28IR-0060 and T31IR1839). The bioinformatics software and computing resources used in the analysis are funded by the USC Office of Research and the Norris Medical Library.

See the rest here:

Vaping not prior smoking is associated with changes in gene regulation linked to disease | Keck School of Medicine of USC - USC News

A Blackburn company has unveiled its disposable vaping range in flavours such as mango and watermelon.

Chief of Vapes said it hadalso secured a contract withBestway Wholsale to supplyall 60 of their depots nationwide.

The company was established by Mubashshir Abdul Aziz and Abdul Mulla in 2018. They have introduced their disposable range in September 2021 and each disposable comes pre-filled with 2ml of e-liquid and delivers approximately 600 puffs.

Mubashshir said: We have an office based on Roman road specialising in manufacturing vaping products.

The disposable range come in 5 flavours including Mango Ice, Watermelon Ice, Blu Raspberry Ice, Energy Ice and Lush Ice with many more to come.

It is a one time use vape disposable which has approximately 600 puffs equivalent to one cigarette pack. They retail at 5.99, half the cost of a pack of cigarettes.

We are one of the very few companies in the UK that are fully compliant with TPD (Tobacco Products Directive) regulations and are listed on the MHRA (Medicines and Healthcare products Regulatory Agency) portal.

The company has come through Covid and are looking to a brighter future thanks to a new partnership with Bestway.

Mubashshir: When Covid-19 hit the industry we stopped all the work at the factory and we could not continue our business in the same manner. We barely survived during the pandemic but as a company we decided not to give up.

We decided to invest into a new product - our disposable vapes Chiefs Totem, which became our lifeline in many ways. We travelled up and down the country to establish business relationships which eventually resulted in success. We are now delighted to be partnering up with Best Way Wholesale.

Mubashshir and Abdul of 'Chief of Vapes'

The products contain nicotine and it is aimed to help people quit smoking.

Mubashshir added: The disposable is designed to be more user friendly and practical than most products on the market, as well as more flavoursome according to the feedback we have received from many consumers and retailers in the UK and EU.

This Device is aimed to assist people quit smoking to live healthier, cleaner and greener lives by making the SWITCH to vaping easier and more effective.

Helping the nation to achieve our Tobacco Control plan and being a smoke free nation by 2030, as studies have shown that vaping is safer than smoking by 95%.

The rest is here:

Blackburn vaping brand announces new partnership with major wholesaler - Lancashire Telegraph

A federal jury in Cleveland found CVS, Walgreens, and Walmart pharmacies responsible for contributing to the opioid crisis; concerns rise after the death of a woman who received infusions of the Alzheimer disease drug Aduhelm; Juul vowed to stop advertising its vaping products to young people in Arizona.

A federal jury said CVS, Walgreens, and Walmart pharmacies recklessly distributed massive amounts of pain pills in 2 Ohio counties, the Associated Press reported. Lake and Trumbull counties argued the 3 chain pharmacies did not stop distributing the pills after they caused hundreds of overdose deaths and cost each county about $1 billion. Attorneys for the pharmacies said they followed policies when pharmacists had concerns and notified authorities of suspicious orders, emphasizing that doctors controlled how many pills were prescribed, not the pharmacists. This verdict comes weeks after juries in Oklahoma and California found multiple drug companies not liable for their roles in the opioid crises in each state, and it could set the tone for other state juries that want to hold pharmacies accountable. CVS Health, Walgreen Co, and Walmart Inc each said they will appeal the verdict.

Concerns about the safety of Biogens Alzheimer disease drug Aduhelm have increased following the death of a 75-year-old woman who died after being infused with the drug, The New York Times reported. The woman lived in Canada and was a participant in a clinical trial for the drug. She died in September, experiencing seizures and brain swelling after receiving infusions of Aduhelm. A doctor reported her death to the FDAs adverse event reporting system, and the death is being investigated by both the FDA and Biogen. In a statement, Biogen said the cause of death is unknown at this time.

Major e-cigarette company Juul Labs is set to pay the state of Arizona $14.5 million in a consumer fraud lawsuit settlement, vowing to stop marketing to young people in the state, as reported by the Associated Press. The agreement requires Juul not to advertise near schools or on social media, nor target anyone under 21. This is the second settlement Juul has reached with Arizona state prosecutors and ends litigation filed in January 2020 against Juul and Eonsmoke claiming the 2 companies illegally targeted younger people in their marketing. Although Arizona previously won a $22.5 million judgment against Eonsmoke, the state has not collected any of the money. Juul Labs stopped all advertising before the lawsuit and admitted no wrongdoing in settling the case, calling it another step in our ongoing effort to reset our company. The company has also stopped selling all flavored products except menthol.

Continue reading here:

What We're Reading: Ohio Pharmacies Liable in Opioid Case; Patient Death on Aduhelm; Juul to Pay $14.5 Million in Vaping Lawsuit - AJMC.com Managed...

Among the restrictions set in place by the Smokefree Environments and Regulated Products (Vaping) Amendment Act which took effect in 2020, is a ban on the sales of vaping products to anyone under 18.

Among the restrictions set in place by the Smokefree Environments and Regulated Products (Vaping) Amendment Act which took effect in 2020, is a ban on the sales of vaping products to anyone under 18, whether these contain nicotine or not. However highlighted Loucas, prior to this regulation being put on paper, there was already an industry code/agreement in place, which saw conscientious vape manufacturers and retailers refraining from selling the products to anyone under 18.

Retailers have had long enough to know right from wrong. I respect the Governments initial focus is on educating retailers about the new law, but its now time to move onto enforcement. There are some tough legislative sanctions for those retailers who continue to let everyone down, and its time they faced the consequences, said Loucas.

A 2019 study had indicated that vape shops play a key role in supporting smokers who switch to safer alternatives. The study titled, I Felt Welcomed in Like Theyre a Little Family in There, I Felt Like I Was Joining a Team or Something: Vape Shop Customers Experiences of E-Cigarette Use, Vape Shops and the Vaping Community, aimed to understand customers experiences of vaping and vape shops, and the extent to which smoking cessation advice is and should be provided in these shops.

The researchers conducted telephone interviews with 22 customers recruited in vape shops in the East Midlands region of England, exploring the participants smoking histories, reasons for using e-cigarettes, the role of vape shops in their e-cigarette use, and whether smoking cessation was discussed in vape shops.

The compiled responses indicated that respondents regarded e-cigarettes as a quitting tool and reported very positive experiences of vaping. The participants found vape shops critical to their positive experiences, in that they provided access to a wide variety of high-quality products and reliable product information and advice.

New Zealands Youth19 Survey Fails to Consider Recent Vape Regulations

Original post:

NZ Vape Retailers Are Urged to Adhere to Age Restrictions - Vaping Post